Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
1
pubmed:dateCreated
2009-7-15
pubmed:abstractText
Melatonin possesses anti-estrogenic effects on estrogen receptor expressing (ER+) breast cancer cells in culture by reducing cell cycle progression and cell proliferation. There is increasing agreement that on a cellular level the effects of melatonin are primarily induced by the membrane-bound receptor MT1. The participation of a second, nuclear receptor of the group of ligand-dependent transcription factors, called RZRalpha, is under debate. In this study we used a number of breast cancer cell lines differing in their expression of the estrogen receptor and the two known melatonin receptors. In MCF-7 breast cancer cells transfected with a vector carrying the MT1 gene (MCF-7Mel1a) binding of CREB-protein to the cAMP-responsive element of the breast cancer suppressing gene BRCA-1 was more strongly reduced by treatment with melatonin than in the parental cells. Expression of estrogen responsive genes was determined in serum-starved cells, cells stimulated for 16 hr with estradiol and cells subsequently treated with melatonin. Expression of BRCA-1, p53, p21(WAF) and c-myc were up-regulated by estradiol. Treatment of the stimulated cells with melatonin counteracted the increase induced by estradiol almost completely. The more MT1 a cell line expressed, the stronger was the reduction of the expression of the estradiol-induced genes. There was no correlation between the expression of the nuclear receptor RZRalpha and the effects of melatonin on these genes.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/BRCA1 Protein, http://linkedlifedata.com/resource/pubmed/chemical/BRCA1 protein, human, http://linkedlifedata.com/resource/pubmed/chemical/CDKN1A protein, human, http://linkedlifedata.com/resource/pubmed/chemical/Cyclin-Dependent Kinase Inhibitor..., http://linkedlifedata.com/resource/pubmed/chemical/Estradiol, http://linkedlifedata.com/resource/pubmed/chemical/MYC protein, human, http://linkedlifedata.com/resource/pubmed/chemical/Melatonin, http://linkedlifedata.com/resource/pubmed/chemical/Proto-Oncogene Proteins c-myc, http://linkedlifedata.com/resource/pubmed/chemical/Receptor, Melatonin, MT1, http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Cytoplasmic and Nuclear, http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Estrogen, http://linkedlifedata.com/resource/pubmed/chemical/Tumor Suppressor Protein p53
pubmed:status
MEDLINE
pubmed:month
Aug
pubmed:issn
1600-079X
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
47
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
23-31
pubmed:meshHeading
pubmed-meshheading:19522736-BRCA1 Protein, pubmed-meshheading:19522736-Breast Neoplasms, pubmed-meshheading:19522736-Cell Cycle, pubmed-meshheading:19522736-Cell Growth Processes, pubmed-meshheading:19522736-Cell Line, Tumor, pubmed-meshheading:19522736-Cyclin-Dependent Kinase Inhibitor p21, pubmed-meshheading:19522736-Down-Regulation, pubmed-meshheading:19522736-Estradiol, pubmed-meshheading:19522736-Female, pubmed-meshheading:19522736-Gene Expression Regulation, Neoplastic, pubmed-meshheading:19522736-Humans, pubmed-meshheading:19522736-Melatonin, pubmed-meshheading:19522736-Proto-Oncogene Proteins c-myc, pubmed-meshheading:19522736-Receptor, Melatonin, MT1, pubmed-meshheading:19522736-Receptors, Cytoplasmic and Nuclear, pubmed-meshheading:19522736-Receptors, Estrogen, pubmed-meshheading:19522736-Reverse Transcriptase Polymerase Chain Reaction, pubmed-meshheading:19522736-Tumor Suppressor Protein p53
pubmed:year
2009
pubmed:articleTitle
Membrane-bound melatonin receptor MT1 down-regulates estrogen responsive genes in breast cancer cells.
pubmed:affiliation
Department of Obstetrics and Gynecology, University of Göttingen, Göttingen, Germany.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't